ACTIVIN RECEPTOR TYPE-1

Approval Year

Substance Class	Protein Created by `admin` on `Tue Apr 01 18:23:16 GMT 2025` Edited by `admin` on `Tue Apr 01 18:23:16 GMT 2025`
Protein Sub Type
Sequence Type	COMPLETE
Record UNII	SX1JPI95HB
Record Status	`Validated (UNII)`
Record Version

Download

Name

Type

Language

ACTIVIN RECEPTOR TYPE-1

Common Name

English

ACTIVIN RECEPTOR-LIKE KINASE 2

Preferred Name

English

SERINE/THREONINE-PROTEIN KINASE RECEPTOR R1

Systematic Name

English

ALK-2

Common Name

English

ALK2

Common Name

English

SKR-1

Common Name

English

SKR1

Common Name

English

TSR-I

Common Name

English

TGF-B SUPERFAMILY RECEPTOR TYPE I

Common Name

English

ACVR1

Common Name

English

Code System Code Type Description

FDA UNII

SX1JPI95HB

Created by admin on Tue Apr 01 18:23:16 GMT 2025 , Edited by admin on Tue Apr 01 18:23:16 GMT 2025

PRIMARY

UNIPROT

Q04771

Created by admin on Tue Apr 01 18:23:16 GMT 2025 , Edited by admin on Tue Apr 01 18:23:16 GMT 2025

PRIMARY

Glycosylation Type

HUMAN

Glycosylation Link Type	Site
N	1_82

Related Record Type Details


					22Z53X5LHF

ITACNOSERTIB

INHIBITOR -> TARGET

Amount:


					616BV6U9G8

THR-184

AGONIST -> TARGET

Comments:

Type I receptor ACVR1, type II receptor ACVR2A and BMP-7 agonist proteins must form a complex to initiate the canonical BMP signaling cascade.

Amount:


					KF4ZI0CJ7M

Fidrisertib

INHIBITOR -> TARGET

Amount:


					6O01GMS00P

MOMELOTINIB

INHIBITOR -> TARGET

Amount:


					Y5293N85Q7

Prafnosbart

LIGAND->TARGET

Amount:


					IT063R5MY0

EPTOTERMIN ALFA

AGONIST -> TARGET

Comments:

Type I receptor ACVR1, type II receptor ACVR2A and BMP-7 agonist proteins must form a complex to initiate the canonical BMP signaling cascade.

Amount:


					8DLP7XK3VH

KER-047

INHIBITOR -> TARGET

Amount:


					716FQ5REVO

ASCRINVACUMAB

INHIBITOR -> TARGET

Amount:


					TIN5O0W1AY

BCX-9250 FREE BASE

INHIBITOR -> TARGET

Comments:

inhibitor of both mutated ALK2 and wild type (wt)ALK2

Amount:


					W69H5YQU9O

LDN-193189

INHIBITOR -> TARGET

Qualification:

IC50

Amount:

Structural Modifications

Modification Type	Location Site	Location Type	Residue Modified	Extent	Fragment Name	Fragment Approval
AMINO ACID SUBSTITUTION	[1_481]				DEXFOSFOSERINE	VI4F0K069V

Name	Property Type	Amount	Referenced Substance	Defining	Parameters	References
MOL_WEIGHT	CHEMICAL
Molecular Formula	CHEMICAL